Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 1998

View Archived Issues

Novalon signs research agreement with Millennium

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Protein Design Labs grants patent license to Genentech

Medarex and Novartis licensing agreement for HuMAb-Mouse technology

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

rHuIL-4 safe in patients with RA; efficacy studies are indicated

HIT study confirms the benefits of raising HDL cholesterol levels

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Preclinical studies indicate OP-1 is effective three days after stroke

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Celecoxib studies continue to generate impressive efficacy and safety data

Prolifix and Chugai extend research collaboration

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

More news from AHA: azimilide prevents atrial fibrillation

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Na+/Ca2+ exchange inhibitors patented by Taisho

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Novel Astra compounds inhibit mast cell, neutrophil and eosinophil activation

Novel aldose reductase inhibitor produced by Corynebacterium

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Oxigene initiates phase I clinical trials of combretastatin

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Pegylated interferon proves superior to standard interferon for treatment of HCV

BTG to commercialize new approach to bacterial vaccines

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...